Carter's (CRI) is a Consumer Cyclical company in the Apparel Retail industry. It has a market capitalization of $1.17B, a trailing price-to-earnings ratio of 8.9 and a free-cash-flow yield of 6.1%. Over the most recent reported fiscal year, revenue grew 1.9% and free cash flow per share fell 71.6%. Nama's AI scorecard rates it Buy, 6.3 out of 10. On 12-month momentum it ranks in the middle band of its market.
AI scorecard
Buy · 6.3/10
Positive, at the low end of Buy. As of Nov 7, 2026.
Momentum
Middle · +4.4% over 12 months ex. last
Middle fifth of its market on the past year's move.
Shariah screen
Not Shariah Compliant
At least one of the three ratios or the industry test failed.
Off its high
-71.2%
How far the last close sits under the highest price of the past five years.
Market cap
$1.17B
Trailing P/E
8.9
Price / book
1.1
Price / sales
0.4
FCF yield
6.1%
Dividend yield
3.1%
Gross margin
44.7%
Operating margin
5.0%
Net margin
3.1%
Revenue growth (YoY)
+1.9%
Revenue growth (3-yr annual)
-3.4%
EPS growth (YoY)
-40.5%
FCF/share growth (YoY)
-71.6%
Beta
0.8
Exchange
NYSE
Sector
Consumer Cyclical
Industry
Apparel Retail
CRI earnings
Next report: Mar 3, 2027 (Q4 2026, EPS estimate $1.50).
Beat the EPS estimate in 4 of 4 recent quarters.
Quarter
Reported
EPS
Estimate
Surprise
Revenue
Q3 2026
Oct 30, 2026
$1.03
$0.85
+21.2%
$752.46M
Q2 2026
Jul 31, 2026
$0.26
$0.06
+333.3%
—
Q1 2026
May 6, 2026
$0.39
$0.13
+200.0%
$681.11M
Q4 2025
Feb 27, 2026
$1.90
$1.70
+11.8%
$925.45M
CRI analyst price target
Median target $35.50 from 6 analysts, ranging $28.00 – $50.00.
Nama's AI scorecard currently rates Carter's Buy (6.3 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is CRI's P/E ratio?
Carter's trades at a trailing price-to-earnings ratio of 8.9.
When does CRI report earnings?
Carter's's next scheduled report is on Mar 3, 2027. Analysts expect EPS of $1.50.
What is the CRI price target?
The median analyst price target from 6 analysts is $35.50, with a range of $28.00 – $50.00.
Is CRI Shariah compliant?
Nama's AAOIFI-style screen reads Carter's as Not Shariah Compliant. At least one of the three ratios or the industry test failed.